Crossmark

Effect of PCSK9 inhibitor on lipoprotein particles in patients with acute coronary syndromes

Published Online: 2021-01-07

Published Print: 2021-12

Authors

Li, Tingting

Zhang, Yingyi

Cong, Hongliang http://orcid.org/0000-0003-1885-5114
License Information

Text and Data Mining valid from 2021-01-07

Version of Record valid from 2021-01-07
More Information

Article History

Received: 23 September 2020

Accepted: 15 December 2020

First Online: 7 January 2021

Ethics approval and consent to participate

: This study was approved by the Medical Ethics Committee of Tianjin Chest Hospital. Informed consents were obtained from all subjects. All patients provided written informed consent.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current